Abstract
Objectives This work aimed at modeling the progressions of COVID-19 cases in time in relation to meteorological factors in large cities of Brazil, Italy, Spain, and USA, and finding the viability of SARS-CoV-2 virus in different weather conditions based on models.
Methods New models constructed showing the relationship of the I′ (the number of infected individuals divided by the total population of a city) with the independent variables -time, temperature, relative humidity, and wind velocity. The regression models fitting in the data were statistically validated by: 1) plot of observed and predicted response; 2) standardized residual plots showing the characteristics of errors; 3) adjusted 
value; 4) the p value for the parameters associated with the various independent variables; and 5) the predictive power of the model beyond data points.
Results Models indicate that 1) the transmission of COVID-19 could be relatively high either for elevated temperatures with lower relative humidity or for lower temperatures with higher relative humidity conditions; 2) disease transmission is expected to be reduced more with higher wind velocity; 3) the rate of increase in the number of COVID-19 cases increases in one model with a constant rate and in the other two with varying rates in time. These transmission features seem to have connections with the structural components of the SARS-CoV-2 virus. Under suitable meteorological conditions, the partial natural disappearance of COVID-19 pandemic could be possible.
Conclusion New models for I′ may be considered to understand the viability of the virus in the environment and future transmission of COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Not Applicable
Funding Statement
No funding was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not Applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
1
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos